Impact of Medication Reconciliation by a Dialysis Pharmacist
- PMID: 36128498
- PMCID: PMC9438412
- DOI: 10.34067/KID.0007182021
Impact of Medication Reconciliation by a Dialysis Pharmacist
Abstract
Integrating a pharmacist into a hemodialysis unit significantly reduced medication discrepancies and medication-related problems over time.Medication reconciliation for the Centers for Medicare and Medicaid Services End-Stage Renal Disease Quality Incentive Program can be optimally performed by a dialysis pharmacist.
Keywords: dialysis; medication discrepancy; medication error; medication reconciliation; medication related problems; medication safety; pharmacist; pharmacy.
Copyright © 2022 by the American Society of Nephrology.
Conflict of interest statement
L. Awdishu reports honoraria from the American Society of Nephrology and the American Board of Internal Medicine and is a member of the American Board of Internal Medicine Nephrology Board. S. Rafie reports consultancy agreements with GenBioPro and TherapeuticsMD; is a scientific advisor for or member of Afaxys; and has participated in a speakers’ bureau for TherapeuticsMD. All remaining authors have nothing to disclose.
Figures
References
-
- Manley HJ, Garvin CG, Drayer DK, Reid GM, Bender WL, Neufeld TK, Hebbar S, Muther RS: Medication prescribing patterns in ambulatory haemodialysis patients: Comparisons of USRDS to a large not-for-profit dialysis provider. Nephrol Dial Transplant 19: 1842–1848, 2004. 10.1093/ndt/gfh280 - DOI - PubMed
-
- Centers for Medicare & Medicaid Services (CMS), HHS : Medicare and Medicaid programs; conditions for coverage for end-stage renal disease facilities. Final rule. Fed Regist 73: 20369–20484, 2008 - PubMed
